Dr. Subramanian Venkatesan
Dr. Subramanian Venkatesan is a clinician scientist. He graduated from Erasmus University Rotterdam in The Netherlands where he studied Medicine and the Master of Neuroscience. He completed a PhD at University College London and The Francis Crick Institute, where he has published in leading journals such as Cancer Discovery, Genome Biology and Annals of Oncology. He works at University College London Hospital at the Department of Oncology and has a special interest in preventative medicine, wearable technologies and research. Within the MedTech space he has co-founded Doc Dialogue and is a clinical lead at Elevate.
Experience
· Co-Founder, Doc Dialogue, Mar 2024 – Present ( https://docdialogue.substack.com/ )
· Medical Doctor, University College London, June 2023 – Present
Education
· PhD in Cancer Research, The Francis Crick Institute / UCL Cancer Institute, London, 2021
· Master of Neuroscience, Erasmus University Rotterdam, 2015
· Master of Science in Medicine, Erasmus University Rotterdam, 2023
Publications
- Investigating chromosomal instability in long-term survivors with glioblastoma and grade 4 astrocytoma
- Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution, Cancer Discovery, 2021
- APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution, Annals of Oncology, 2018
- Evolutionary dynamics in pre-invasive neoplasia, Current Opinion in Systems Biology, 2017
- Genetic biomarkers of drug response for small molecule therapeutics targeting the PI3K-,TP53- and RB-pathway in Glioblastoma, CNS Oncology, 2016